CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $546,373
- in 2 filings
Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-28 | Greenleaf Peter Chief Executive Officer | Grant or award | +290,728 | 1,815,780 | ||
| 2025-02-28 | Greenleaf Peter Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +443,973 | 443,973 | ||
| 2025-02-28 | Keenan Greg Chief Medical Officer | Grant or award | +62,583 | 174,028 | ||
| 2025-02-28 | Keenan Greg Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +95,570 | 95,570 | ||
| 2025-02-28 | Miller Joseph M Chief Financial Officer | Grant or award | +81,457 | 580,663 | ||
| 2025-02-28 | Miller Joseph M Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +124,393 | 124,393 | ||
| 2025-02-28 | Robertson Stephen P. EVP, General Counsel | Grant or award | +84,106 | 529,349 | ||
| 2025-02-28 | Robertson Stephen P. EVP, General Counsel | Grant or award · Employee Stock Option (right to buy) | +128,438 | 128,438 | ||
| 2025-02-28 | Donley Matthew Maxwell Chief Operating Officer | Grant or award | +82,781 | 669,791 | ||
| 2025-02-28 | Donley Matthew Maxwell Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +126,416 | 126,416 | ||
| 2025-02-28 | TANG KEVIN Director | Purchase | +399,280 | $7.85 | $3.1M | 8,828,780 |
| 2024-12-09 | TANG KEVIN Director | Purchase | +500,000 | $9.09 | $4.5M | 8,429,500 |
| 2024-12-06 | TANG KEVIN Director | Purchase | +400,000 | $9.01 | $3.6M | 7,929,500 |
| 2024-12-05 | TANG KEVIN Director | Purchase | +300,000 | $8.91 | $2.7M | 7,529,500 |
| 2024-11-21 | Smith Karen L. Director | Grant or award | +12,135 | 24,807 | ||
| 2024-11-21 | Smith Karen L. Director | Grant or award · Director Stock Option (right to buy) | +18,641 | 18,641 | ||
| 2024-11-21 | Leversage Jill Director | Grant or award | +12,135 | 25,053 | ||
| 2024-11-21 | Leversage Jill Director | Grant or award · Director Stock Option (right to buy) | +18,641 | 18,641 | ||
| 2024-11-21 | Johnson Craig A Director | Grant or award | +20,631 | 20,631 | ||
| 2024-11-21 | Johnson Craig A Director | Grant or award · Director Stock Option (right to buy) | +31,688 | 31,688 |
Page 5 of 10 · 197 trades